Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Report January-September 2018

Third quarter ·  Revenue increased by 50.9 per cent to SEK 445.2 (295.1) million ·  Organic growth was 36.4 per cent ·  EBITDA increased by 49.4 per cent to SEK 75.5 (50.6) million ·  EBITDA margin was 17.0 (17.1) per cent ·  Earnings per share after dilution rose by 36.0 per cent to SEK 0.99 (0.73) ·  Cash flow from operating activities SEK 107.2 (135.4) million ·  Customer deposits increased by 72.3 per cent to SEK 1,477.7 million January–September ·  Revenue increased by 44.2 per cent to SEK 1,239.0 (859.0) million ·  EBITDA rose by 21.6 per cent to SEK

Interim report Q3 of Cloetta AB July - September 2018

Continued growth within brands and improved EBIT• Net sales for the quarter increased by 2.2 per cent to SEK 1,538m (1,505) including a positive impact from foreign exchange rates of 5.8 per cent. • Operating profit amounted to SEK 180m (169). Profit for the period from continuing operations amounted to SEK 132m (108). Operating profit, adjusted for items affecting comparability, amounted to SEK 194m (169). • Cash flow from operating activities amounted to SEK 250m (135). • Net debt/EBITDA ratio was 2.48x (2.63). Please find enclosed the full report. The interim report will

IMPACT COATINGS AB (PUBL), INTERIM REPORT JULY-SEPTEMBER 2018

FINANCIAL RESULTS THIRD QUARTER 2018 · Net sales amounted to SEK 5 305 thousand (6 964) · Operating profit amounted to SEK -8 758 thousand (-4 103) · Net income after financial items amounted to SEK -8 760 thousand (-4 898) · Cash flow amounted to SEK 7 037 thousand (-11 719) · Equity-to-assets ratio amounted to 62.5% (42.7) FINANCIAL RESULTS JANUARY-SEPTEMBER 2018 · Net sales amounted to SEK 16 469 thousand (28 198) · Operating profit amounted to SEK -28 385 thousand (-18 505) · Net income after financial items amounted to SEK -28 406 thousand (-19 306) ·

Skanska develops and sells new office building in Jönköping, Sweden, for about SEK 500 M

Skanska Sweden invests in an office building in central Jönköping. The property is simultaneously sold to Vacse for about SEK 500 M. The Swedish Agencies for Agriculture and Forestry (Jordbruksverket and Skogsstyrelsen) becomes tenants. The construction contract, amounting to SEK 330 M, is awarded to Skanska Sweden and will be booked in the fourth quarter 2018. The transaction will be reported in the Commercial Property Development stream in the fourth quarter of 2018.Construction work begins in October this year with the aim of having the building completed and handed over in early 2021.

Neste's Interim Report for January-September 2018

Neste Corporation Interim Report 26 October 2018 at 9 am. (EET) Excellent quarter - outstanding performance in Renewable Products Third quarter in brief: ·  Comparable operating profit totaled EUR 395 million (EUR 350 million) ·  Operating profit totaled EUR 250 million (EUR 339 million) ·  Renewable Products' comparable sales margin was USD 645/ton (USD 435/ton) ·  Oil Products' total refining margin was USD 12.41/bbl (USD 11.96/bbl) ·  Cash flow before financing activities was EUR 108 million (EUR 283 million) January-September in brief: ·  Comparable

Tikkurila's Business Review for January–September 2018

Tikkurila OyjStock Exchange ReleaseOctober 26, 2018 at 9:00 a.m. (CET+1)Tikkurila's Business Review for January–September 2018 Sales volumes were on the rise in almost all key markets, currencies significantly decreased revenue and profitability. Contrary to expectations, raw material inflation continued to be strong, weakening profitability and reducing the impact of increases in sales prices. Measures to improve cost-efficiency continued.   Tikkurila’s revenue for the third quarter decreased by 5 percent to EUR 152.2 million (7–9/2017: EUR 159.9 million). Revenue grew by 2

Interim Report July–September 2018

Third Quarter · Revenue increased by 16.3% to €167.4m (€144.0m). Organic revenue grew by 13.8%. · Operating profit amounted to €7.4m (€8.5m), representing an operating margin of 4.4% (5.9%). · Net profit amounted to €6.2m (€4.3m), which represents a net profit margin of 3.7% (3.0%). · Cash flow from operating activities amounted to €21.8m (€15.3m). · Basic/diluted earnings per share (EPS) were €0.042 (€0.030). · EBITDA increased by 0.7% to €15.1m (€15.0m), corresponding to an EBITDA margin of 9.0% (10.4%). Nine Months · Revenue increased by 14.7% to €490.4m (€427.

MyFC Holding (publ) financial report January – September 2018

The quarter July – September 2018 · Net sales: KSEK 202 (6) · Operating loss: MSEK -15.4 (-10.7) · Earnings per share: SEK -0,22 kr (-0,33)Significant events July – September 2018 · MyFC runs an electric car on water at Almedalen political week · myFC makes key recruitment within mobile integration · myFC ships JAQ Hybrid to Lightec Japan Significant events after the end of the period · myFC makes adjustments in the Group Leadership Team · myFC showcases prototype smartphone charged by integrated fuel cell · myFC launches JAQ Hybrid in Japan together with

C-RAD AB – Interim report January-September 2018

Press release 2018-10-26 C-RAD REPORTS ALL-TIME HIGH IN QUARTELY ORDER INTAKE THIRD QUARTER 2018  · Order intake: 64.2 (55.5) MSEK, 16%. · Revenues: 46.7 (33.2) MSEK, 41%. · Operating profit: 0.4 (-1.4) MSEK. · Net results after tax: 0.3 (-1.7) MSEK · Result per share: 0.01 (-0.05) SEK. · Sahlgrenska University Hospital selects C-RAD’s innovative SIGRT solution.Order value: 8.5 MSEK. · MedAustron, the first Ion-therapy treatment site in Austria, selected C-RAD Catalyst PT. Order value: 4.9 MSEK. Comments from Tim Thurn, CEO: SUBSTANTIAL PROGRESS ON

C-RAD AB – Interim report January-September 2018

Press release 2018-10-26 C-RAD REPORTS ALL-TIME HIGH IN QUARTELY ORDER INTAKE THIRD QUARTER 2018  · Order intake: 64.2 (55.5) MSEK, 16%. · Revenues: 46.7 (33.2) MSEK, 41%. · Operating profit: 0.4 (-1.4) MSEK. · Net results after tax: 0.3 (-1.7) MSEK · Result per share: 0.01 (-0.05) SEK. · Sahlgrenska University Hospital selects C-RAD’s innovative SIGRT solution.Order value: 8.5 MSEK. · MedAustron, the first Ion-therapy treatment site in Austria, selected C-RAD Catalyst PT. Order value: 4.9 MSEK. Comments from Tim Thurn, CEO: SUBSTANTIAL PROGRESS ON

Outotec warns about possible material additional costs related to a large project

OUTOTEC OYJ STOCK EXCHANGE RELEASE   OCTOBER 26, 2018 at 9:00 AM Outotec warns about possible material additional costs related to a large project Outotec has delivered a first-of-its-kind ilmenite smelter, with two large alternating current (AC) electric furnaces, as part of a greenfield plant delivery signed in 2012. Both furnaces had their challenges during the original start-ups in 2015 and 2016. Furnace 1 was repaired and rebuilt, but during the ongoing start-up of the repaired furnace, there were problems and the start-up operation was terminated. Investigation of the furnace

MSAB: Need for decentralized solutions on the rise

MSAB: Need for decentralized solutions on the rise January - September · Net sales increased 0.4 percent to SEK 217.7 (216.9) million (-2 percent in local currencies). · EBIT for the year amounted to SEK 24.0 (51.9) million. · The EBIT margin reached 11.0 (23.9) percent. · Profit after tax amounted to SEK 20.4 (38.8) million. · Earnings per share were SEK 1.10 (2.12). · Cash flow from operating activities amounted to SEK -23.7 (-2.7) million. · Cash and cash equivalents and short-term investments amounted to SEK 70.5 (76.3) million at the end of the period.

Dates for SSAB’s financial reports in 2019

Dates for SSAB’s financial reports in 2019 and the AGM.January 29, 2019               Financial statement release (year-end report) for 2018 April 25, 2019                     Q1 – Interim report for January-March 2019 July 19, 2019                      Q2 –Interim report for January-June 2019 October 23, 2019                Q3 – Interim report for January-September 2019 Reports are published at 7.30am CET/CEST on the release date unless otherwise announced. The Annual Report 2018 will be published in week 12. The Annual General Meeting 2019 will be held in Stockholm on

CEO and President Magnus Welander comments on the Thule Group (publ) Interim Report for the third quarter, July-September, 2018

A stable quarter with major launch effortsThird quarter sales rose to SEK 1,561m (1,385), up 12.7 percent (3.8 percent after currency adjustment). Accordingly, sales increased SEK 461m (up 5.6 percent after currency adjustment) in the first three quarters of the year. During the quarter EBIT increased 3.4 percent and for the first three quarters operating income has grown by SEK 97m (up 9.6 percent).The third quarter was dominated by major launches for the future which led to increased development and launch costs of approx. SEK 25m year-on-year.Thule’s longstanding market leading

Nomination Committee for Volati AB’s 2019 Annual General Meeting

Volati AB’s Nomination Committee for the 2019 Annual General Meeting has been appointed. The Nomination Committee is composed of the following members:  - Carin Wahlén (Nomination Committee Chairman) representing the Chairman of the Board Patrik Wahlén  - Karl Perlhagen representing himself  - Jannis Kitsakis representing the Fourth Swedish National Pension Fund  The Nomination Committee for the 2019 AGM is therefore the same as for the 2018 AGM, apart from the fact that the Fourth Swedish National Pension Fund is now represented on the Committee as the third-largest shareholder.

Thule Group (publ) – Interim report for the third quarter, July-September 2018

· Net sales for the third quarter amounted to SEK 1,561m (1,385), corresponding to an increase of 12.7 percent. Adjusted for exchange rate fluctuations, sales rose 3.8 percent. · Operating income totaled SEK 267m (258), corresponding to an increase of 3.4 percent and a margin of 17.1 percent (18.6). Adjusted for exchange rate fluctuations, operating income decreased 3.0 percent. · Net income was SEK 189m (185). · Cash flow from operating activities totaled SEK 499m (519). · Earnings per share before dilution amounted to SEK 1.83 (1.81). The full report is available at

Redeye: Acconeer should still be on your radar (updated post-Q3 version)

This is an updated version of our initiating coverage report from last week. We have made negligible revisions in our 2018 estimates related to short-term cost assumptions where we now expect an EBIT of SEK -35m (-39m) for 2018. Other than that the rest of the initial report, our estimates, valuation and investment case etc. are exactly the same and just as relevant as the first version. Download the research update: http://bit.ly/2RdAdU7  Start following companies at Redeye to recieve the latest research withtin Life Science and Technology. This is a press release from Redeye -

SSAB to invest in increased Q&T steel production capacity

SSAB is to invest a total of around SEK 1 billion in SSAB Americas’ steel mill in Mobile, Alabama to increase production capacity for quenched and tempered (Q&T) steels and to reduce costs. The investments will take place during 2019-2021 and will increase the annual capacity of Q&T in Mobile from 300,000 tonnes to 400,000 tonnes. Taking into account the cost savings, the payback time is estimated to be less than four years.“SSAB is a global leader in Q&T steels and we have largely driven market growth through application development together with customers. Over the past 20 years, we have

Redeye: Formpipe - Solid Q3 as expected – SaaS migration taking a break

In total, Formpipe’s Q3 report was solid and in line with our expectations. Our key takeaway from this report is the fact that Microsoft Dynamics’ migration to SaaS inflated the ACV levels in H2 2017. The lowered SaaS estimates are, however, neutralized by increased forecasts for S&M and on-premises sales. We do not make any major adjustments to our estimates, and we keep our Base case at SEK 17. Read more in the Research Update by Johan Svantesson: http://bit.ly/2OMZDuW  Start following companies at Redeye to instantly receive our latest equity research. This is a press release

Kindred Group plc - Interim report January – September 2018 (unaudited)

Third quarter and the period January to September highlights · Gross winnings revenue amounted to GBP 230.7 (193.6) million for the third quarter of 2018, an increase of 19 per cent, and GBP 657.5 (513.4) million for the period January to September 2018. · Underlying EBITDA for the third quarter of 2018 was GBP 55.7 (46.8) million, and GBP 144.9 (110.5) million for the period January to September 2018. · Strong cash flows of GBP 57.1 (47.7) million generated from operating activities before movements in working capital in the third quarter 2018 and GBP 148.6 (109.1) million for the

Ahlsell Q3 2018: The Ahlsell model delivers and brings record sales

Third quarter 2018 · Net sales increased by 15% to MSEK 7,458 (6,492). Organic growth was 7% (10). · Operating profit (EBIT) was MSEK 524 (510). · Profit (EBITA) amounted to MSEK 620 (597), with an EBITA margin of 8.3% (9.2). EBITA includes items affecting comparability of MSEK -30. Adjusted EBITA increased by 9% to MSEK 650 (597), with an adjusted EBITA margin of 8.7% (9.2). · Profit after tax increased by 14% to MSEK 367 (323). · Diluted earnings per share amounted to SEK 0.86 (0.74). · Cost-saving measures have been intensified during the quarter. These measures are,

XVIVO Perfusion AB (publ) Interim Report January – September 2018

GOOD SALES GROWTH DRIVEN BY WARM PERFUSIONTHIRD QUARTER 2018 (JUL - SEP) • Total net sales in the quarter amounted to SEK 40.9 (32.3) million, corresponding to an increase of 27 percent. The increase corresponds to 18 percent in local currency. Net sales of non-durable goods in the quarter amounted to SEK 40.3 (31.6) million, corresponding to an increase of 27 percent in SEK. Sales of non-durable goods increased by 18 percent in local currency.• Sales from warm perfusion* showed a growth record of more than 60 percent during the quarter. Sales from warm perfusion represented 40 percent

Report for the third quarter of 2018: SSAB Americas leads the continued earnings improvement

The quarter · Sales were SEK 19,038 (16,188) million · Operating profit before depreciation/amortization and items affecting comparability was SEK 2,563 (2,016) million  · Operating profit, excluding items affecting comparability, was SEK 1,600 (1,089) million · Operating profit, including items affecting comparability of SEK -213 million, was SEK 1,387 (1,089) million · Earnings per share were SEK 0.85 (0.56) · Operating cash flow was SEK 1,922 (1,590) million · Net debt/equity ratio was 17% (27%)Comments by the CEO SSAB’s operating profit, excluding items

Catella divests Wealth Management operations in Luxembourg to VP Bank

Catella Bank S.A., a fully owned subsidiary of Catella AB (publ), has entered an asset transfer-agreement to divest its Wealth Management operations in Luxembourg to VP Bank (Luxembourg) SA as part of the previously announced strategic review, for approximately SEK 110 Million.The Swedish Wealth Management division and the Card Issuing-operations is not part of this transaction and the strategic review is ongoing with regards to these two operations. As previously announced Catella aim to exit the consolidated situation due to the extensive regulatory framework and inefficient capital-

There are no items matching the current filter
There are no more items matching the current filter
Back to top